首页> 美国卫生研究院文献>PLoS Clinical Trials >Growth Factor Priming Differentially Modulates Components of the Extracellular Matrix Proteome in Chondrocytes and Synovium-Derived Stem Cells
【2h】

Growth Factor Priming Differentially Modulates Components of the Extracellular Matrix Proteome in Chondrocytes and Synovium-Derived Stem Cells

机译:启动因子的生长因子差异调节软骨细胞和滑膜衍生干细胞中细胞外基质蛋白质组的成分。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To make progress in cartilage repair it is essential to optimize protocols for two-dimensional cell expansion. Chondrocytes and SDSCs are promising cell sources for cartilage repair. We previously observed that priming with a specific growth factor cocktail (1 ng/mL transforming growth factor-β1, 5 ng/mL basic fibroblast growth factor, and 10 ng/mL platelet-derived growth factor-BB) in two-dimensional culture, led to significant improvement in mechanical and biochemical properties of synovium-derived stem cell (SDSC)-seeded constructs. The current study assessed the effect of growth factor priming on the proteome of canine chondrocytes and SDSCs. In particular, growth factor priming modulated the proteins associated with the extracellular matrix in two-dimensional cultures of chondrocytes and SDSCs, inducing a partial dedifferentiation of chondrocytes (most proteins associated with cartilage were down-regulated in primed chondrocytes) and a partial differentiation of SDSCs (some collagen-related proteins were up-regulated in primed SDSCs). However, when chondrocytes and SDSCs were grown in pellet culture, growth factor-primed cells maintained their chondrogenic potential with respect to glycosaminoglycan and collagen production. In conclusion, the strength of the label-free proteomics technique is that it allows for the determination of changes in components of the extracellular matrix proteome in chondrocytes and SDSCs in response to growth factor priming, which could help in future tissue engineering strategies.
机译:为了在软骨修复方面取得进展,必须优化二维细胞扩增方案。软骨细胞和SDSCs是用于软骨修复的有前途的细胞来源。我们先前观察到在二维培养中使用特定生长因子混合物(1μng/ mL转化生长因子-β1、5μng / mL碱性成纤维细胞生长因子和10μng/ mL血小板衍生的生长因子-BB)引发,导致滑膜来源的干细胞(SDSC)种子构建体的机械和生化特性显着改善。目前的研究评估了生长因子启动对犬软骨细胞和SDSCs蛋白质组的影响。特别是,生长因子启动调节了软骨细胞和SDSCs二维培养中与细胞外基质相关的蛋白质,导致软骨细胞部分去分化(大多数与软骨相关的蛋白质在被刺激的软骨细胞中被下调)和SDSCs的部分分化。 (一些与胶原蛋白相关的蛋白质在启动的SDSC中上调)。但是,当软骨细胞和SDSCs在沉淀培养中生长时,生长因子引发的细胞在糖胺聚糖和胶原蛋白产生方面仍保持着软骨形成的潜力。总之,无标记蛋白质组学技术的优势在于,它可以确定软骨细胞和SDSC中细胞外基质蛋白质组中响应生长因子启动的成分的变化,这可能有助于将来的组织工程策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号